Dyadic International, Inc.(DYAI)Earnings, Financials & Key Ratios
DYAI•NASDAQ
$0.76
$28M mkt cap·Price updated May 6, 2026
AboutDyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.Show more
- Revenue$3M+20.6%
- EBITDA-$5M+34.3%
- Net Income-$6M+14.5%
- EPS (Diluted)-0.20+16.7%
- Gross Margin65.82%+106.7%
- EBITDA Margin-153.95%+45.5%
- Operating Margin-168.82%+40.5%
- Net Margin-166.19%+29.1%
- ROE-139.16%-73.7%
- ROIC-1669.28%-548.3%
- Debt/Equity2.05+8704.6%
- Interest Coverage-13.79
DYAI Key Insights
Dyadic International, Inc. (DYAI) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Strong 5Y sales CAGR of 15.8%
✗Weaknesses
- ✗High debt to equity ratio of 2.1x
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
DYAI Price & Volume
Dyadic International, Inc. (DYAI) stock price & volume — 10-year historical chart
Loading chart...
DYAI Growth Metrics
Dyadic International, Inc. (DYAI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-11.98%
5 Years15.77%
3 Years13.29%
TTM-21.88%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-16.08%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-10.08%
Return on Capital
10 Years-41.62%
5 Years-68.92%
3 Years-83.67%
Last Year-87.75%
DYAI Peer Comparison
Dyadic International, Inc. (DYAI) competitors in Drug Discovery and Antibody Platforms — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 CDXS | 241.71M | 2.66 | -5.32 | 18.61% | -62.47% | -90.51% | 1.45 | |
 GEVO | 497.05M | 2.05 | -14.64 | 8.49% | 0.75% | 0.25% | 0.01 | |
 TWST | 3.71B | 59.53 | -45.79 | 20.32% | -19.85% | -17.46% | 0.29 | |
 SEER | 105.44M | 1.89 | -1.36 | -8.13% | -486.02% | -29.19% | 0.08 | |
 BEAM | 3.32B | 32.33 | -39.92 | 120.01% | -57.24% | -7.31% | 0.24 | |
 BNGO | 13.64M | 1.27 | -0.26 | -7.37% | -92.59% | -56.22% | 0.16 | |
 MRK | 280.48B | 113.56 | 15.60 | 1.18% | 28.12% | 36.14% | 0.96 | |
 PFE | 150.77B | 26.51 | 19.49 | -1.65% | 11.83% | 8.34% | 0.78 |
Compare DYAI vs Peers
Dyadic International, Inc. (DYAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DYAI Income Statement
Dyadic International, Inc. (DYAI) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 592.89K | 758.42K | 1.3M | 1.68M | 1.6M | 2.4M | 2.93M | 2.9M | 3.5M | 2.63M |
| Revenue Growth % | 87.79% | 27.92% | 70.81% | 29.77% | -4.71% | 50.06% | 21.9% | -1.07% | 20.58% | -21.88% |
| Cost of Goods Sold | 516.16K | 680.2K | 1.03M | 1.46M | 1.42M | 1.94M | 2.12M | 1.98M | 1.19M | 1.52M |
| COGS % of Revenue | 87.06% | 89.69% | 79.3% | 86.83% | 88.95% | 80.89% | 72.46% | 68.16% | 34.18% | - |
| Gross Profit | 76.72K▲ 0% | 78.22K▲ 2.0% | 268.17K▲ 242.8% | 221.38K▼ 17.5% | 176.99K▼ 20.0% | 459.39K▲ 159.6% | 807.11K▲ 75.7% | 922.96K▲ 14.4% | 2.3M▲ 149.3% | 1.11M▲ 0% |
| Gross Margin % | 12.94% | 10.31% | 20.7% | 13.17% | 11.05% | 19.11% | 27.54% | 31.84% | 65.82% | 42.22% |
| Gross Profit Growth % | -59.98% | 1.95% | 242.83% | -17.45% | -20.05% | 159.56% | 75.69% | 14.35% | 149.28% | - |
| Operating Expenses | 5.88M | 7.45M | 7.84M | 9.5M | 10.2M | 15.19M | 10.97M | 9.15M | 8.2M | 8.3M |
| OpEx % of Revenue | 992.54% | 982.85% | 605.18% | 565.35% | 636.9% | 631.78% | 374.46% | 315.74% | 234.64% | - |
| Selling, General & Admin | 4.56M | 5.03M | 4.52M | 5.52M | 6.08M | 6.7M | 6.42M | 5.82M | 6.13M | 5.95M |
| SG&A % of Revenue | 769.48% | 663.27% | 349.12% | 328.36% | 379.84% | 278.62% | 219.14% | 200.67% | 175.51% | - |
| Research & Development | 885.6K | 2.2M | 3.32M | 5.42M | 3.87M | 8.39M | 4.5M | 3.3M | 2.04M | 2.02M |
| R&D % of Revenue | 149.37% | 290.48% | 256.06% | 322.18% | 241.47% | 349.12% | 153.61% | 113.75% | 58.48% | - |
| Other Operating Expenses | 436.92K | 220.72K | 0 | -1.43M | 249.73K | 96.89K | 49.92K | 38.42K | 22.56K | 318.03K |
| Operating Income | -5.96M▲ 0% | -7.13M▼ 19.7% | -7.59M▼ 6.5% | -9.28M▼ 22.3% | -10.03M▼ 8.0% | -14.73M▼ 46.9% | -10.17M▲ 31.0% | -8.23M▲ 19.0% | -5.9M▲ 28.3% | -7.19M▲ 0% |
| Operating Margin % | -1004.45% | -939.7% | -586.09% | -552.18% | -625.85% | -612.67% | -346.92% | -283.9% | -168.82% | -273.42% |
| Operating Income Growth % | -63.32% | -19.67% | -6.53% | -22.26% | -8% | -46.9% | 30.97% | 19.04% | 28.3% | - |
| EBITDA | -147.34K | 249.06K | -188.78K | -27.73K | -9.96M | -11.24M | -10.12M | -8.19M | -5.38M | -6.91M |
| EBITDA Margin % | -24.85% | 32.84% | -14.57% | -1.65% | -621.96% | -467.48% | -345.21% | -282.58% | -153.95% | -262.83% |
| EBITDA Growth % | 97.47% | 269.04% | -175.8% | 85.31% | -35836.22% | -12.79% | 9.98% | 19.02% | 34.31% | -74.61% |
| D&A (Non-Cash Add-back) | 5.81M | 7.38M | 7.4M | 9.25M | 0 | 3.49M | 0 | 38.42K | 0 | 0 |
| EBIT | -5.81M | -7.38M | -7.57M | -9.25M | -9.96M | -14.63M | -10.12M | -8.19M | -5.38M | -6.91M |
| Net Interest Income | 484.58K | 566.15K | 894.53K | 984.93K | 447K | 51.7K | 180.42K | 416.69K | 29.02K | -134.76K |
| Interest Income | 485.49K | 0 | 0 | 984.93K | 447K | 51.7K | 180.42K | 416.69K | 456.99K | 304.8K |
| Interest Expense | 909 | 566.15K | 894.53K | 0 | 0 | 0 | 0 | 0 | 427.97K | 439.56K |
| Other Income/Expense | 2.58M | 4.92M | 894.53K | 984.93K | 731.71K | 1.66M | 430.42K | 1.43M | 91.66K | -161.27K |
| Pretax Income | -3.37M▲ 0% | -2.2M▲ 34.7% | -6.7M▼ 204.1% | -8.3M▼ 23.9% | -9.29M▼ 12.0% | -13.07M▼ 40.6% | -9.74M▲ 25.5% | -6.8M▲ 30.2% | -5.81M▲ 14.5% | -7.35M▲ 0% |
| Pretax Margin % | -568.52% | -290.41% | -517.03% | -493.59% | -580.18% | -543.73% | -332.23% | -234.42% | -166.19% | -279.56% |
| Income Tax | 238.07K | -66.69K | -1.01M | 10.31K | 31.32K | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | -7.06% | 3.03% | 15.02% | -0.12% | -0.34% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.61M▲ 0% | -2.14M▲ 40.8% | -5.69M▼ 166.5% | -8.31M▼ 46.0% | -9.33M▼ 12.2% | -13.07M▼ 40.2% | -9.74M▲ 25.5% | -6.8M▲ 30.2% | -5.81M▲ 14.5% | -7.35M▲ 0% |
| Net Margin % | -608.67% | -281.61% | -439.36% | -494.21% | -582.13% | -543.73% | -332.23% | -234.42% | -166.19% | -279.56% |
| Net Income Growth % | -105.49% | 40.82% | -166.49% | -45.96% | -12.25% | -40.16% | 25.52% | 30.2% | 14.51% | -16.08% |
| Net Income (Continuing) | -3.61M | -2.14M | -5.69M | -8.31M | -9.33M | -13.07M | -9.74M | -6.8M | -5.81M | -7.35M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.10▲ 0% | -0.07▲ 25.2% | -0.21▼ 184.2% | -0.31▼ 47.6% | -0.34▼ 9.7% | -0.47▼ 38.2% | -0.34▲ 27.7% | -0.24▲ 29.4% | -0.20▲ 16.7% | -0.21▲ 0% |
| EPS Growth % | -105.17% | 25.2% | -184.17% | -47.62% | -9.68% | -38.24% | 27.66% | 29.41% | 16.67% | -10.08% |
| EPS (Basic) | -0.10 | -0.07 | -0.21 | -0.31 | -0.34 | -0.47 | -0.34 | -0.24 | -0.20 | - |
| Diluted Shares Outstanding | 36.54M | 28.92M | 27.67M | 27M | 27.47M | 27.84M | 28.36M | 28.8M | 29.32M | 34.51M |
| Basic Shares Outstanding | 36.54M | 28.92M | 27.67M | 27M | 27.47M | 27.84M | 28.36M | 28.8M | 29.32M | 34.51M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
DYAI Balance Sheet
Dyadic International, Inc. (DYAI) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 57.63M | 49.62M | 42.75M | 35.64M | 29.78M | 21.01M | 13.42M | 8.07M | 9.83M | 11.55M |
| Cash & Short-Term Investments | 48.94M | 47.69M | 41.2M | 34.22M | 29.09M | 20.26M | 12.64M | 7.26M | 9.26M | 10.25M |
| Cash Only | 6.89M | 5.79M | 2.39M | 4.82M | 20.64M | 15.75M | 5.79M | 6.52M | 6.51M | 7.16M |
| Short-Term Investments | 42.05M | 41.9M | 38.82M | 29.4M | 8.46M | 4.51M | 6.85M | 748.29K | 2.76M | 3.1M |
| Accounts Receivable | 1.08M | 760.87K | 1.12M | 1.14M | 294.2K | 372.21K | 330K | 466.16K | 237.03K | 950.69K |
| Days Sales Outstanding | 665.72 | 366.18 | 315.52 | 247.21 | 67.03 | 56.52 | 41.11 | 58.7 | 24.75 | 73.76 |
| Inventory | 7.36M | 1.02M | 253.45K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | 5.21K | 544.76 | 90.05 | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 112.25K | 0 | 58.28K | 10.08K | 24.25K | 339.94K |
| Total Non-Current Assets | 1.07M | 1.13M | 552.75K | 1.81M | 290.93K | 290.83K | 290.75K | 151.9K | 102.61K | 127.5K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 141.44K | 92.21K | 52.4K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | 20.50x | 37.91x | 36.28x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 1.07M | 922.65K | 500.62K | 1.76M | 284.71K | 284.71K | 284.71K | 0 | 0 | 474.23K |
| Other Non-Current Assets | 5.85K | 205.74K | 52.14K | 51.31K | 6.22K | 6.12K | 6.04K | 10.46K | 10.4K | 287.04K |
| Total Assets | 58.7M▲ 0% | 50.74M▼ 13.6% | 43.3M▼ 14.7% | 37.45M▼ 13.5% | 30.07M▼ 19.7% | 21.3M▼ 29.2% | 13.71M▼ 35.6% | 8.22M▼ 40.1% | 9.93M▲ 20.8% | 11.67M▲ 0% |
| Asset Turnover | 0.01x | 0.01x | 0.03x | 0.04x | 0.05x | 0.11x | 0.21x | 0.35x | 0.35x | 0.28x |
| Asset Growth % | -23.43% | -13.55% | -14.67% | -13.51% | -19.71% | -29.17% | -35.62% | -40.06% | 20.82% | -32.35% |
| Total Current Liabilities | 1.01M | 768.89K | 849.64K | 1.59M | 1.63M | 2.56M | 2.45M | 2.25M | 2.45M | 4.05M |
| Accounts Payable | 279.06K | 520.26K | 309.06K | 793K | 1.01M | 1.55M | 1.28M | 656.45K | 482.32K | 705.83K |
| Days Payables Outstanding | 197.33 | 279.18 | 109.81 | 198.29 | 259.51 | 290.57 | 219.41 | 121.27 | 147.37 | 142.71 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 48.93K |
| Deferred Revenue (Current) | 216.32K | 0 | 141K | 78.64K | 0 | 147.06K | 0 | 0 | 0 | 1.34M |
| Other Current Liabilities | 515.56K | 100.67K | 141K | 242K | 123.02K | 151.15K | 217.21K | 490.11K | 833.81K | 1.47M |
| Current Ratio | 57.04x | 64.53x | 50.31x | 22.44x | 18.32x | 8.22x | 5.48x | 3.58x | 4.01x | 4.01x |
| Quick Ratio | 49.75x | 63.21x | 50.01x | 22.44x | 18.32x | 8.22x | 5.48x | 3.58x | 4.01x | 4.01x |
| Cash Conversion Cycle | 5.68K | 631.76 | 295.76 | - | - | - | - | - | - | -68.95 |
| Total Non-Current Liabilities | 495.38K | 520.26K | 309.06K | 0 | 0 | 352.94K | 176.47K | 88.87K | 5.01M | 5.01M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.98M | 5.01M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 88.87K | 34.62K | 59.67K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 176.47K | 0 | 0 | -1 |
| Total Liabilities | 1.01M | 768.89K | 849.64K | 1.59M | 1.63M | 2.91M | 2.63M | 2.34M | 7.46M | 9.07M |
| Total Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 136.93K | 5.07M | 5.06M |
| Net Debt | -6.89M | -5.79M | -2.39M | -4.82M | -20.64M | -15.75M | -5.79M | -6.38M | -1.44M | -2.09M |
| Debt / Equity | - | - | - | - | - | - | - | 0.02x | 2.05x | 2.05x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -0.73x |
| Net Debt / EBITDA | - | -23.23x | - | - | - | - | - | - | - | 0.30x |
| Interest Coverage | -6551.43x | -12.59x | -8.49x | - | - | - | - | - | -13.79x | -15.72x |
| Total Equity | 57.69M▲ 0% | 49.98M▼ 13.4% | 42.45M▼ 15.1% | 35.86M▼ 15.5% | 28.45M▼ 20.7% | 18.39M▼ 35.4% | 11.09M▼ 39.7% | 5.88M▼ 47.0% | 2.47M▼ 58.0% | 2.61M▲ 0% |
| Equity Growth % | -21.82% | -13.37% | -15.06% | -15.52% | -20.68% | -35.35% | -39.71% | -46.98% | -57.98% | -277.83% |
| Book Value per Share | 1.58 | 1.73 | 1.53 | 1.33 | 1.04 | 0.66 | 0.39 | 0.20 | 0.08 | 0.08 |
| Total Shareholders' Equity | 57.69M | 49.98M | 42.45M | 35.86M | 28.45M | 18.39M | 11.09M | 5.88M | 2.47M | 2.61M |
| Common Stock | 38.93K | 38.94K | 38.97K | 39.61K | 39.75K | 40.48K | 40.82K | 41.06K | 42.09K | 48.44K |
| Retained Earnings | -25.2M | -27.35M | -33.04M | -41.35M | -50.68M | -63.75M | -73.48M | -80.28M | -86.09M | -91.88M |
| Treasury Stock | -10.4M | -16.63M | -18.93M | -18.93M | -18.93M | -18.93M | -18.93M | -18.93M | -18.93M | -18.93M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DYAI Cash Flow Statement
Dyadic International, Inc. (DYAI) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -6.04M | -2.61M | -4.41M | -5.78M | -6.57M | -11.28M | -8.08M | -6.73M | -3.97M | -3.97M |
| Operating CF Margin % | -1017.97% | -343.64% | -340.2% | -344% | -410.41% | -469.12% | -275.87% | -232.05% | -113.72% | - |
| Operating CF Growth % | -651.91% | 56.82% | -69.1% | -31.21% | -13.69% | -71.53% | 28.32% | 16.79% | 40.91% | -778.53% |
| Net Income | -3.61M | -2.14M | -5.69M | -8.31M | -9.33M | -13.07M | -9.74M | -6.8M | -5.81M | -7.35M |
| Depreciation & Amortization | 0 | 0 | 676.64K | 0 | 0 | 0 | 0 | 0 | 0 | 10.34K |
| Stock-Based Compensation | 624.81K | 643.43K | 467.2K | 0 | 0 | 1.78M | 1.89M | 1.24M | 0 | 840.3K |
| Deferred Taxes | 0 | 0 | -676.64K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -359.59K | -273.09K | 697.42K | 1.4M | 1.76M | -1.18M | 83.71K | -1.03M | 1.08M | 221.85K |
| Working Capital Changes | -2.69M | -840.78K | 119.94K | 1.13M | 990.08K | 1.19M | -321.17K | -143.21K | 754.53K | 1.65M |
| Change in Receivables | -513.47K | 333.02K | -59.98K | 218.62K | 1.08M | -13.92K | -47.17K | -93.13K | 205.26K | -561.97K |
| Change in Inventory | -1.96M | -1.21M | 234.68K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -339.74K | 207.43K | -195.75K | 657.66K | -53.2K | 549.56K | -248.13K | -651.17K | -180.18K | 610.79K |
| Cash from Investing | -42.56M | 103K | 3.33M | 7.71M | 22.12M | 5.22M | -2.37M | 7.45M | -1.88M | 877.2K |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 |
| CapEx % of Revenue | - | - | - | 0% | 0% | - | - | - | 0% | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -42.56M | -812.08K | 3.33M | 0 | 0 | 0 | 0 | 0 | 0 | 5 |
| Cash from Financing | -13.12M | -6.22M | -2.3M | 550.19K | 255.47K | 1.23M | 543.59K | 0 | 5.85M | 4.99M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.82M | -5.82M |
| Equity Issued (Net) | -1000K | -1000K | -1000K | 550.19K | 255.47K | 0 | 0 | 0 | 24.25K | 1.05M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -13.29M | -6.22M | -2.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 66.13K | 1.44K | 4.5K | 0 | 0 | 1.23M | 543.59K | 0 | 0 | 5.82M |
| Net Change in Cash | -61.71M▲ 0% | -8.47M▲ 86.3% | -3.4M▲ 59.8% | 2.44M▲ 171.7% | 15.81M▲ 548.8% | -4.89M▼ 130.9% | -9.95M▼ 103.6% | 720.76K▲ 107.2% | -8.28K▼ 101.1% | 1.48M▲ 0% |
| Free Cash Flow | -6.04M▲ 0% | -2.61M▲ 56.8% | -4.41M▼ 69.1% | -5.78M▼ 31.2% | -6.57M▼ 13.7% | -11.28M▼ 71.5% | -8.08M▲ 28.3% | -6.73M▲ 16.8% | -3.97M▲ 40.9% | -4.63M▲ 0% |
| FCF Margin % | -1017.97% | -343.64% | -340.2% | -344% | -410.41% | -469.12% | -275.87% | -232.05% | -113.72% | -176.09% |
| FCF Growth % | -651.91% | 56.82% | -69.1% | -31.21% | -13.69% | -71.53% | 28.32% | 16.79% | 40.91% | -10.16% |
| FCF per Share | -0.17 | -0.09 | -0.16 | -0.21 | -0.24 | -0.41 | -0.28 | -0.23 | -0.14 | -0.14 |
| FCF Conversion (FCF/Net Income) | 1.67x | 1.22x | 0.77x | 0.70x | 0.71x | 0.86x | 0.83x | 0.99x | 0.68x | 0.63x |
| Interest Paid | 909 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 108K |
| Taxes Paid | 11.5K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DYAI Key Ratios
Dyadic International, Inc. (DYAI) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -5.49% | -3.97% | -12.32% | -21.22% | -29% | -55.81% | -66.05% | -80.11% | -139.16% | -281.83% |
| Return on Invested Capital (ROIC) | -15.95% | -11.25% | -13.52% | -19.58% | -38.71% | -211.37% | -192.16% | -257.5% | -1669.28% | -1669.28% |
| Gross Margin | 12.94% | 10.31% | 20.7% | 13.17% | 11.05% | 19.11% | 27.54% | 31.84% | 65.82% | 42.22% |
| Net Margin | -608.67% | -281.61% | -439.36% | -494.21% | -582.13% | -543.73% | -332.23% | -234.42% | -166.19% | -279.56% |
| Debt / Equity | - | - | - | - | - | - | - | 0.02x | 2.05x | 2.05x |
| Interest Coverage | -6551.43x | -12.59x | -8.49x | - | - | - | - | - | -13.79x | -15.72x |
| FCF Conversion | 1.67x | 1.22x | 0.77x | 0.70x | 0.71x | 0.86x | 0.83x | 0.99x | 0.68x | 0.63x |
| Revenue Growth | 87.79% | 27.92% | 70.81% | 29.77% | -4.71% | 50.06% | 21.9% | -1.07% | 20.58% | -21.88% |
DYAI Frequently Asked Questions
Dyadic International, Inc. (DYAI) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Dyadic International, Inc. (DYAI) reported $2.6M in revenue for fiscal year 2024. This represents a 1144% increase from $0.2M in 2003.
Dyadic International, Inc. (DYAI) grew revenue by 20.6% over the past year. This is strong growth.
Dyadic International, Inc. (DYAI) reported a net loss of $7.3M for fiscal year 2024.
Dividend & Returns
Dyadic International, Inc. (DYAI) has a return on equity (ROE) of -139.2%. Negative ROE indicates the company is unprofitable.
Dyadic International, Inc. (DYAI) had negative free cash flow of $4.6M in fiscal year 2024, likely due to heavy capital investments.
Explore More DYAI
Dyadic International, Inc. (DYAI) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates